Court OKs Change to ‘Fen-Phen’ Settlement
- Share via
Wyeth said a U.S. District Court judge had approved an amendment to a national settlement of lawsuits over its recalled “fen-phen” diet drugs that would streamline the payment of $1.28 billion for the least serious claims.
The May 2004 amendment, which is still subject to appeal, would create a new claims processing structure, funding arrangement and payment schedule for the least serious but most numerous claims, according to Madison, N.J.-based Wyeth.
The amendment would ensure that these claims were processed on a streamlined basis, while preserving funds in the existing trust for more serious claims, the company said.
Wyeth shares fell $1.44 to $39.83 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
